GE HealthCare Technologies Inc. (GEHC : NASDAQ)
Common Stock
$65.74
USD
+1.45 (2.26%)
Last updated: 2026-10-05
Follow GEHC
GEHC
GE HealthCare Technologies Inc.
WealthAwesomePerformance
1 Day
+2.26%
1 Week
-1.56%
1 Month
-4.53%
YTD
-20.51%
Key Statistics
Market Cap
$29.69B
52W High
$89.64
52W Low
$58.72
P/E Ratio
15.11
50 Day MA
$68.72
200 Day MA
$71.28
Beta
0.85
Dividend Yield
0.22%
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 10/5/2026 | $63.62 | $65.86 | $63.37 | $65.74 | $65.74 | 3,662,772 |
| 10/2/2026 | $64.73 | $64.98 | $63.95 | $64.29 | $64.29 | 3,243,800 |
| 10/1/2026 | $65.37 | $65.55 | $63.86 | $63.98 | $63.98 | 3,308,900 |
| 9/30/2026 | $66.34 | $66.55 | $65.37 | $65.37 | $65.37 | 2,727,800 |
| 9/29/2026 | $66.32 | $66.76 | $65.61 | $66.46 | $66.46 | 3,311,800 |
| 9/28/2026 | $66.29 | $67.10 | $65.96 | $66.78 | $66.78 | 4,166,200 |
| 9/25/2026 | $66.20 | $67.01 | $65.75 | $66.63 | $66.63 | 4,159,300 |
| 9/24/2026 | $66.14 | $66.48 | $65.19 | $66.38 | $66.38 | 3,966,300 |
| 9/23/2026 | $66.16 | $66.46 | $65.63 | $66.09 | $66.09 | 3,169,300 |
| 9/22/2026 | $66.28 | $67.09 | $66.00 | $66.27 | $66.27 | 3,941,300 |
Analyst Price Targets
Based on 20 analysts covering GEHC · as of Oct 5, 2026
Wall Street analysts forecast GEHC stock price to rise 26.3% over the next 12 months.
Consensus
Buy4.25 / 5.00
Avg. Target
US$83.05
+26.3% Upside
Current Price
US$65.74
Last close
Analyst Breakdown (20 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on GEHC's historical volatility
30-Day Vol
19.5%
Annualized
90-Day Vol
34.6%
Annualized
Trend (90d)
+6.9%
Annualized drift
90d Mean
US$67.39
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$66.28 | US$61.97 – US$70.90 |
| 60 trading days | US$66.83 | US$60.77 – US$73.51 |
| 90 trading days | US$67.39 | US$59.98 – US$75.72 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Financials
- Revenue (TTM)
- $21.27B
- EBITDA
- $3.59B
- Profit Margin
- 9.33%
- ROE (TTM)
- 19.38%
- EPS (Diluted)
- 4.35
- Book Value
- 24.30
Classification
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Group
- Health Care Equipment & Services
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About GEHC.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| GUTS | Fractyl Health, Inc. Common Stock | $4.56 | +1020.39% |
| CMND | Clearmind Medicine Inc. Common Shares | $6.00 | +739.16% |
| AMPGZ | Amplitech Group, Inc. Series B Right | $0.24 | +74.48% |
| VEEA | Veea Inc. | $5.72 | +71.77% |
| PDSB | PDS Biotechnology Corp | $1.20 | +60.21% |
| BEAT | Heartbeam Inc | $0.65 | +50.39% |
| RITRF | Reitar Logtech Holdings Limited | $0.01 | +42.86% |
| QTEX | QTREX Quantum Ltd. | $1.54 | +40.00% |
GEHC.US news timeline
6 articles covering GEHC.US, most recent first
Latest